Suffering from an aggressive form of leukemia, 13-year-old Leen Faytrouni had exhausted all other treatment options when she agreed to be the first pediatric patient at City of Hope to participate in a study of a new drug
Leen Faytrouni
Subscribe to our CancerCenter Newsletter
Thank you
Keep an eye on your inbox for the latest City of Hope news and research breakthroughs. If you have previously subscribed to receive email communications, your preferences have been updated.